In general, conversely to what has been demonstrated in the general population and neurodegenerative diseases, findings from our and the abovementioned studies suggest a protective role of BDNF Val/Met polymorphism against cognitive decline and brain atrophy in MS patients. The gene discussed is BDNF; the disease is neurodegenerative disease.